Provided by Tiger Fintech (Singapore) Pte. Ltd.

Integra Lifesciences

17.35
+0.66003.95%
Post-market: 17.350.00000.00%16:35 EDT
Volume:1.06M
Turnover:18.32M
Market Cap:1.34B
PE:-192.41
High:17.54
Open:16.66
Low:16.41
Close:16.69
Loading ...

1 Small-Cap Stock with Solid Fundamentals and 2 to Steer Clear Of

StockStory
·
Yesterday

Q4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks

StockStory
·
17 Apr

Spotting Winners: Teleflex (NYSE:TFX) And Surgical Equipment & Consumables - Specialty Stocks In Q4

StockStory
·
15 Apr

Truist Cuts Price Target on Integra LifeSciences Holdings to $19 From $26, Keeps Hold Rating

MT Newswires Live
·
11 Apr

Top Stock Reports for Cisco, Caterpillar & CME

Zacks
·
04 Apr

Integra LifeSciences Raised to Buy From Hold by Argus Research

Dow Jones
·
31 Mar

Argus Upgrades Integra LifeSciences to Buy From Hold, Price Target is $28

MT Newswires Live
·
31 Mar

Integra (IART) Down 7.5% Since Last Earnings Report: Can It Rebound?

Zacks
·
27 Mar

Winners And Losers Of Q4: Integra LifeSciences (NASDAQ:IART) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks

StockStory
·
27 Mar

Is This the Right Time to Hold Integra Stock in Your Portfolio?

Zacks
·
26 Mar

Q4 Earnings Review: Surgical Equipment & Consumables - Specialty Stocks Led by Intuitive Surgical (NASDAQ:ISRG)

StockStory
·
24 Mar

3 Reasons IART is Risky and 1 Stock to Buy Instead

StockStory
·
14 Mar

Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

GlobeNewswire
·
14 Mar

Integra LifeSciences Price Target Maintained With a $35.00/Share by Citizens Capital Markets

Dow Jones
·
26 Feb

Stock Track | Integra Lifesciences Plummets 5.02% as Quality and Supply Chain Issues Linger

Stock Track
·
26 Feb

Integra LifeSciences Holdings Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
26 Feb

Sell Rating on Integra Lifesciences Amidst Uncertain Growth and Leadership Transition

TIPRANKS
·
26 Feb

Integra Lifesciences Faces Supply Chain Challenges and Conservative Outlook, Leading to Sell Rating

TIPRANKS
·
26 Feb

Integra Lifesciences Holdings Corp (IART) Q4 2024 Earnings Call Highlights: Strong Revenue ...

GuruFocus.com
·
26 Feb

Q4 2024 Integra Lifesciences Holdings Corp Earnings Call

Thomson Reuters StreetEvents
·
26 Feb